Skip to content
Rameda Pharma
Rameda Pharma
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact
Corporate Website
  • ع
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact

Author Archives: admin

You are here:
  1. Home
  2. Article author admin
Details

Standalone financial statements for the period ended 31 December 2022

Standalone Financial StatementsBy adminMarch 7, 2023
Details

Consolidated financial statements for the period ended 31 December 2022

Consolidated Financial Statements resultsBy adminMarch 7, 2023
Details

Rameda FY22 Earnings Release

Earings ReleasesBy adminMarch 7, 2023

Annual Corporate Governance Disclosure Report

Regulatory DisclosuresBy adminMarch 7, 2023

Annual ESG Disclosure Report

Regulatory DisclosuresBy adminMarch 7, 2023

Disclosure to EGX on BOD minutes

Regulatory DisclosuresBy adminMarch 7, 2023
Details

Board of Directors Report – FY22

Board and Shareholders ActionsBy adminMarch 7, 2023
Details

BOD Meeting Minutes on 6 March 2023

Board and Shareholders ActionsBy adminMarch 7, 2023

Rameda Reports its FY22 Results

Corporate NewsBy adminMarch 7, 2023

Disclosure to the EGX on the Organizational Structure

Regulatory DisclosuresBy adminJanuary 9, 2023
←1
23456
…7891011…
12131415161718192021222324252627282930313233343536
37→

All Rights Reserved © 2024

Go to Top